Basic neuropharmacology of antidepressants relevant to the pharmacotherapy of depression

Clinical Cornerstone - Tập 1 - Trang 17-30 - 1999
Elliott Richelson1
1Department of Research and Department of Psychiatry and Psychology Mayo Clinic Jacksonville Jacksonville, Florida, USA

Tài liệu tham khảo

Briley, 1993, Neurobiological mechanisms involved in antidepressant therapies, Clin Neuropharmacol, 16, 387, 10.1097/00002826-199310000-00002 Heninger, 1996, The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans, Pharmacopsychiatry, 29, 2, 10.1055/s-2007-979535 Richelson, 1994, Pharmacology of antidepressantscharacteristics of the ideal drug, 69, 1069 Richelson, 1997, Review of antidepressants in the treatment of mood disorders, 286 Tatsumi, 1997, Pharmacological profile of antidepressants and related compounds at human monoamine transporters, Eur J Pharmacol, 340, 249, 10.1016/S0014-2999(97)01393-9